Treatment With a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma Cruzi-Infected Mice
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01738
Full Text
Open PDFAbstract
Available in full text
Date
December 11, 2017
Authors
Publisher
Frontiers Media SA